Ensemble Learning for Higher Diagnostic Precision in Schizophrenia Using Peripheral Blood Gene Expression Profile
Open Access
- 1 May 2024
- journal article
- research article
- Published by Taylor & Francis in Neuropsychiatric Disease and Treatment
- Vol. ume 20, 923-936
Abstract
Introduction: Stigma contributes to a significant part of the burden of schizophrenia (SCZ), therefore reducing false positives from the diagnosis would be liberating for the individuals with SCZ and desirable for the clinicians. The stigmatization associated with schizophrenia advocates the need for high-precision diagnosis. In this study, we present an ensemble learning-based approach for high-precision diagnosis of SCZ using peripheral blood gene expression profiles. Methodology: The machine learning (ML) models, support vector machines (SVM), and prediction analysis for microarrays (PAM) were developed using differentially expressed genes (DEGs) as features. The SCZ samples were classified based on a voting ensemble classifier of SVM and PAM. Further, microarray-based learning was used to classify RNA sequencing (RNA-Seq) samples from our case-control study (Pune-SCZ) to assess cross-platform compatibility. Results: Ensemble learning using ML models resulted in a significantly higher precision of 80.41% (SD: 0.04) when compared to the individual models (SVM-radial: 71.69%, SD: 0.04 and PAM 77.20%, SD: 0.02). The RNA sequencing samples from our case-control study (Pune-SCZ) resulted in a moderate precision (59.92%, SD: 0.05). The feature genes used for model building were enriched for biological processes such as response to stress, regulation of the immune system, and metabolism of organic nitrogen compounds. The network analysis identified RBX1, CUL4B, DDB1, PRPF19, and COPS4 as hub genes. Conclusion: In summary, this study developed robust models for higher diagnostic precision in psychiatric disorders. Future efforts will be directed towards multi-omic integration and developing “explainable” diagnostic models.Keywords
All Related Versions
This publication has 63 references indexed in Scilit:
- Stigmatization of schizophrenic individuals and its correlation to the fear of violent offence. Should we be concerned?Annals of Medicine & Surgery, 2022
- A novel multi-class classification model for schizophrenia, bipolar disorder and healthy controls using comprehensive transcriptomic dataComputers in Biology and Medicine, 2022
- Gene expression profiling in peripheral blood mononuclear cells of early-onset schizophreniaGenomics Data, 2015
- Gene expression analysis reveals schizophrenia-associated dysregulation of immune pathways in peripheral blood mononuclear cellsJournal of Psychiatric Research, 2013
- Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: Convergent pathway analysis findings from two independent samplesAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2010
- Schizophrenia and increased risks of cardiovascular diseaseAmerican Heart Journal, 2005
- Gene expression analysis of peripheral blood leukocytes from discordant sib-pairs with schizophrenia and bipolar disorder reveals points of convergence between genetic and functional genomic approachesAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2005
- Assessing the validity of blood‐based gene expression profiles for the classification of schizophrenia and bipolar disorder: A preliminary reportAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2005
- Higher Natural Killer Cell Activity in Schizophrenic Patients: The Impact of Serum Factors, Medication, and SmokingBrain, Behavior, and Immunity, 2000
- Support-vector networksMachine Learning, 1995